Background antihistamine used at the end of four months.
| Group A | Group B | ||
|---|---|---|---|
| Antihistamine used (%) | Loratadine | 38.7 | 33.3 |
| Desloratadine | 25.8 | 26.7 | |
| Cetirizine | 9.7 | 11.1 | |
| Levocetirizine | 19.4 | 11.1 | |
| Fexofenadine | 6.5 | 17.8 | |
| Total | 100 | 100 | |
| Median dose of antihistamine used (mg/day) | Loratadine | 10 | 10 |
| Desloratadine | 5 | 5 | |
| Cetirizine | 10 | 20 | |
| Levocetirizine | 5 | 10 | |
| Fexofenadine | 60 | 180 | |
We thank Monkwriter (https://monkwriter.com/) for providing professional assistance in scientific writing of this article.
SSS: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing—original draft. AD: Data curation, Formal analysis, Validation, Writing—review & editing, Supervision. S Moitra: Methodology, Resources, Supervision, Writing—review & editing. S Mukherjee: Investigation, Resources, Writing—review & editing. NC: Resources, Validation, Writing—review & editing. SRJ: Supervision, Project administration, Funding acquisition. All authors read and approved the submitted version.
The authors declare that they have no conflicts of interest.
The study was approved by the Institutional Ethics Committee, Allergy and Asthma Treatment Centre, Moulali, Kolkata, West Bengal, India (approval no. HREC-AARC/37). Because of the retrospective design, the requirement of informed consent was waived. Our study was conducted in accordance with the principles outlined in the Declaration of Helsinki (2024 revision) as adopted by the World Medical Association.
As this was a retrospective study based on existing records, individual informed consent was waived by the Institutional Ethics Committee.
Not applicable.
The data supporting the findings of this study are available from the corresponding author upon reasonable request.
This study was funded by “Geno Pharmaceuticals Pvt. Ltd.”. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
© The Author(s) 2025.
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.